14:00 - 14:10

Welcome & Introductions 

14:10 - 14:30

MS Pathophysiology Update 2025

Amit Bar-Or, MD

14:30 - 15:00

McDonald Criteria 2024 & Clinical Courses

Fred D. Lublin, MD

15:00 - 15:30

Advanced MRI and How to Implement in Clinical Practice 

Jiwon Oh, MD

15:30 - 16:00

Fluid Biomarkers 

Hans-Peter Hartung, MD

16:00 - 16:15

Panel Discussion

16:15 - 16:30

Break

16:30 - 17:00

Debate – Is All MS Progressive? 

Daniel Ontaneda, MD
Gavin Giovannoni, MD

17:00 - 17:30

Overall Treatment Strategy 

Xavier Montalban, MD

17:30 - 18:30

Novel Therapeutic Approaches to Multiple Sclerosis: BTK and Second-Generation Anti-CD40 Therapeutics 

Supported by an educational grant from Sanofi

Ludwig Kappos, MD

18:30 - 19:00

Cellular Therapies Including CAR-T 

Jiwon Oh, MD

19:00 - 19:30

Biosimilars

Mark Freedman, MD

19:30 - 19:45

Introduction to Remyelination 

Catherine Lubetzki, MD

19:45 - 20:00

Symptom Management 

Daniel Ontaneda, MD